Bayer's stock has dropped to its lowest since 2009 following the failure of its blood-thinner drug trial. The trial's failure has cast doubt on a $5 billion drug, causing Bristol Myers' stock to slump by 4.6%. Additionally, Bayer is facing legal setbacks over its Roundup weedkiller, leading to a $1.56 billion loss. Moody's has downgraded Bayer's outlook to negative from stable due to the series of drug pipeline and legal setbacks. The company's chief attributes the thin drug pipeline to years of under-investment.
Bayer chief blames thin drug pipeline on ‘years of under-investment’ https://t.co/t64jaQsMp9
Bayer had its outlook lowered to negative from stable by Moody’s after a series of drug pipeline and legal setbacks that have sent its shares and bonds tumbling https://t.co/0ERyQ7mfN0
Bayer had its outlook lowered to negative from stable by Moody’s after a series of drug pipeline and legal setbacks that have sent its shares and bonds tumbling https://t.co/eqKyfKVzAL
Bayer said it didn’t know the results of its blood-thinner drug trial, which was halted this week, before selling $5.75 billion of bonds to investors https://t.co/2dut3lHBS4
Bayer said it didn’t know the results of its blood-thinner drug trial, which was halted this week, before selling $5.75 billion of bonds to investors https://t.co/DAB1OwjvbO
The calls for a break up of Bayer may grow as woes from its Monsanto deal deepen. Yet a split looks harder than ever, @hughes_chris writes https://t.co/CJ0fL1ExYE via @opinion
Bayer to pay $1.56B in latest loss over cancer-causing Roundup weedkiller https://t.co/rW7B2rEiuf https://t.co/VhrsGqE73T
$BMY (-4.6% pre) Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug - TheStreet https://t.co/m2onnFSDGN
Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug https://t.co/ojMgivtkOE
Drugmaker Bayer Stock Drops to Lowest Since 2009 as Blood Thinner Trial Fails https://t.co/45O4SnSKiE